Literature DB >> 31529767

Association of the eukaryotic vaginal virome with prophylactic antibiotic exposure and reproductive outcomes in a subfertile population undergoing in vitro fertilisation: a prospective exploratory study.

A M Eskew1, M J Stout2, B S Bedrick1, J K Riley1, K R Omurtag1, P T Jimenez1, R R Odem1, V S Ratts1, S L Keller1, E S Jungheim1, K M Wylie3,4.   

Abstract

OBJECTIVE: The objective of this study was to use high-throughput sequencing to describe the vaginal eukaryotic DNA virome in patients undergoing in vitro fertilisation (IVF) to examine associations between the vaginal virome, antibiotic exposure and IVF outcomes.
DESIGN: Prospective exploratory study.
SETTING: Single academic fertility centre. POPULATION: Subfertile women age 18-43 years undergoing their first IVF cycle with a fresh embryo transfer.
METHODS: The primary exposure was prophylactic azithromycin or no azithromycin before IVF. A mid-vaginal swab was obtained at the time of embryo transfer for virome analysis. MAIN OUTCOME MEASURES: The primary outcomes compared between exposure groups were characteristics of vaginal virome and clinical pregnancy rates. Secondary outcomes were virome associations with number of oocytes retrieved, number of blastocysts and implantation rate.
RESULTS: Twenty-six women contributed a vaginal swab before embryo transfer. There were no significant differences in IVF outcomes between azithromycin groups. There was no association between viral diversity and clinical pregnancy overall. A higher diversity of herpesviruses and α-papillomaviruses was observed in samples from the azithromycin-treated group compared with the no azithromycin group (P = 0.04). In women that received azithromycin, viral diversity was higher in the group that did not achieve clinical pregnancy compared with those who did (P = 0.06).
CONCLUSIONS: We demonstrate that the vaginal eukaryotic virome in women undergoing IVF is associated with antibiotic exposure. Additionally, we demonstrate an inverse trend between viral diversity and pregnancy, with a higher number of viruses detected associated with failure to achieve clinical pregnancy in the azithromycin group. TWEETABLE ABSTRACT: Higher viral diversity is associated with prophylactic antibiotic exposure in subfertile women undergoing IVF.
© 2019 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Embryo transfer; in vitro fertilisation; reproductive tract microbiome; vaginal virus; virome

Mesh:

Substances:

Year:  2019        PMID: 31529767      PMCID: PMC6910962          DOI: 10.1111/1471-0528.15951

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  28 in total

Review 1.  Inflammation in reproductive disorders.

Authors:  Gerson Weiss; Laura T Goldsmith; Robert N Taylor; Dominique Bellet; Hugh S Taylor
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

2.  Detection of Viruses in Clinical Samples by Use of Metagenomic Sequencing and Targeted Sequence Capture.

Authors:  Kristine M Wylie; Todd N Wylie; Richard Buller; Brandi Herter; Maria T Cannella; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

Review 3.  Risk assessment and management to prevent preterm birth.

Authors:  B Koullali; M A Oudijk; T A J Nijman; B W J Mol; E Pajkrt
Journal:  Semin Fetal Neonatal Med       Date:  2016-02-18       Impact factor: 3.926

4.  Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.

Authors:  Avraham Beigelman; Megan Isaacson-Schmid; Geneline Sajol; Jack Baty; Oscar M Rodriguez; Erin Leege; Kevin Lyons; Toni L Schweiger; Jie Zheng; Kenneth B Schechtman; Mario Castro; Leonard B Bacharier
Journal:  J Allergy Clin Immunol       Date:  2014-11-18       Impact factor: 10.793

5.  Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors:  Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

6.  Evidence that the endometrial microbiota has an effect on implantation success or failure.

Authors:  Inmaculada Moreno; Francisco M Codoñer; Felipe Vilella; Diana Valbuena; Juan F Martinez-Blanch; Jorge Jimenez-Almazán; Roberto Alonso; Pilar Alamá; Jose Remohí; Antonio Pellicer; Daniel Ramon; Carlos Simon
Journal:  Am J Obstet Gynecol       Date:  2016-10-04       Impact factor: 8.661

7.  Vaginal Microbiota and In Vitro Fertilization Outcomes: Development of a Simple Diagnostic Tool to Predict Patients at Risk of a Poor Reproductive Outcome.

Authors:  Thor Haahr; Peter Humaidan; Helle Olesen Elbaek; Birgit Alsbjerg; Rita Jakubcionyte Laursen; Kåre Rygaard; Thor Bech Johannesen; Paal Skytt Andersen; Kim Lee Ng; Jørgen Skov Jensen
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

8.  Enhanced virome sequencing using targeted sequence capture.

Authors:  Todd N Wylie; Kristine M Wylie; Brandi N Herter; Gregory A Storch
Journal:  Genome Res       Date:  2015-09-22       Impact factor: 9.043

9.  Metagenomic analysis of double-stranded DNA viruses in healthy adults.

Authors:  Kristine M Wylie; Kathie A Mihindukulasuriya; Yanjiao Zhou; Erica Sodergren; Gregory A Storch; George M Weinstock
Journal:  BMC Biol       Date:  2014-09-10       Impact factor: 7.431

10.  Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner.

Authors:  Smita Gopinath; Myoungjoo V Kim; Tasfia Rakib; Patrick W Wong; Michael van Zandt; Natasha A Barry; Tsuneyasu Kaisho; Andrew L Goodman; Akiko Iwasaki
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

View more
  7 in total

Review 1.  The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease.

Authors:  Ferralita S Madere; Cynthia L Monaco
Journal:  Curr Opin Virol       Date:  2021-11-17       Impact factor: 7.090

2.  The Medium Is the Message: Defining a "Normal" Vaginal Microbiome in Healthy Reproductive-Age Women.

Authors:  Steven S Witkin; Iara Moreno Linhares
Journal:  Reprod Sci       Date:  2022-08-18       Impact factor: 2.924

3.  ViroMatch: A Computational Pipeline for the Detection of Viral Sequences from Complex Metagenomic Data.

Authors:  Todd N Wylie; Kristine M Wylie
Journal:  Microbiol Resour Announc       Date:  2021-03-04

4.  Association of vaginal bacterial communities and reproductive outcomes with prophylactic antibiotic exposure in a subfertile population undergoing in vitro fertilization: a prospective exploratory study.

Authors:  Ashley M Eskew; Molly J Stout; Bronwyn S Bedrick; Joan K Riley; Brandi N Herter; Haley Gula; Emily S Jungheim; Kristine M Wylie
Journal:  F S Sci       Date:  2021-01-11

Review 5.  Diversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity.

Authors:  Parakriti Gupta; Mini P Singh; Kapil Goyal
Journal:  Front Public Health       Date:  2020-07-24

6.  Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study.

Authors:  Andrea Carosso; Alberto Revelli; Gianluca Gennarelli; Stefano Canosa; Stefano Cosma; Fulvio Borella; Annalisa Tancredi; Carlotta Paschero; Lara Boatti; Elisa Zanotto; Francesca Sidoti; Paolo Bottino; Cristina Costa; Rossana Cavallo; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2020-07-15       Impact factor: 3.412

Review 7.  The Vaginal Virome-Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes?

Authors:  Anna-Ursula Happel; Arvind Varsani; Christina Balle; Jo-Ann Passmore; Heather Jaspan
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.